Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Tongji Hospital
Centre Leon Berard
Peking University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Centre Oscar Lambret
Medical College of Wisconsin
University of California, Irvine
Sun Yat-sen University
Northwell Health
M.D. Anderson Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Campania Luigi Vanvitelli
Sun Yat-sen University
UNICANCER
Peking University Cancer Hospital & Institute
Shanghai Zhongshan Hospital
Peking University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
UNICANCER
Maimónides Biomedical Research Institute of Córdoba
Assistance Publique - Hôpitaux de Paris
UNICANCER
UNICANCER
Massachusetts General Hospital
Grupo Espanol Multidisciplinario del Cancer Digestivo
Sun Yat-sen University
GERCOR - Multidisciplinary Oncology Cooperative Group
Weill Medical College of Cornell University
Shanghai Pudong Hospital
Zhejiang Cancer Hospital
Nanjing Tianyinshan Hospital
Federation Francophone de Cancerologie Digestive
Federation Francophone de Cancerologie Digestive
City of Hope Medical Center
McGill University Health Centre/Research Institute of the McGill University Health Centre
University of Campania Luigi Vanvitelli
St. Olavs Hospital
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Shanghai Zhongshan Hospital
Big Ten Cancer Research Consortium
Fudan University
Fox Chase Cancer Center
Centre Hospitalier Universitaire Dijon
Memorial Sloan Kettering Cancer Center
Sixth Affiliated Hospital, Sun Yat-sen University
Stanford University
Azienda Ospedaliera Universitaria Integrata Verona
University Hospital Tuebingen